Clinical Trials Browser

Phase 4 × NIH × Adalimumab × Clear all

NCT00837434 2021-09-22

Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

Phase 4 Completed

63 enrolled 26 charts

Arthritis, Rheumatoid